We are committed to becoming a leader in the healthcare industry that is trusted by customers, recognized by employees, and respected by society

Invest in science and talents,

continue to leverage 

commercialization advantages,

provide high-quality medicines and 

solutions that improve lives of people 

and create social value.

Integrity

Agility

Innovation

Ownership

In the future, the unmet medical needs in the fields of chronic diseases and critical care related diseases will be growing and generate large marketing potentials.

Rooted in China with a global perspective, Hasten will connect the upstream and downstream industrial chains through the layout of "whole industry" and "globalization". We will enrich product structure and pipelines in diversified ways and rely on the broad medical and health platform and resources of CBC Group, as well as invest in science and talents to continuously leverage commercialization advantages.

We are committed to becoming a leader in the healthcare industry. We will work closely with our stakeholders such as relevant government institutions, medical and health professionals and industry partners to continuously drive the management ecosystem of chronic diseases & critical care related diseases, aiming to build a leading innovative medical and healthcare enterprise in China so as to benefit more patients and create social value.